$ADMA News

ADMA Biologics: The Earnings Reset Still Leaves More Upside

ADMA Biologics Inc (ADMA) (Q2 2026) Earnings Call Highlights: Ascentiv Surges 24% as Gross ...

ADMA Biologics (NASDAQ:ADMA) Shares Slide as Q2 Results Miss Estimates

ADMA Biologics Q2 Earnings Call Highlights

ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update

ADMA Biologics, Inc. (ADMA) Q2 2026 Earnings Call Transcript

ADMA Biologics Affirms FY2026 Sales Guidance of $530.000M-$560.000M vs $559.495M Est

ADMA Biologics Q2 Adj. EPS $0.16 Misses $0.17 Estimate, Sales $124.395M Miss $131.658M Estimate

Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note

Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?

ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026

Adma Biologics (ADMA) Rises Higher Than Market: Key Facts

ADMA Biologics (ADMA) Faces Class Actions And Probes Over Revenue Allegations

Mizuho Maintains Outperform on ADMA Biologics, Lowers Price Target to $17

ADMA Biologics (ADMA) Stock Looks Undervalued Even After A 5 Year Run

Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key Insights

Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?

BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?

Is ADMA Stock's 13.5% Monthly Gain a Sign of Recovery?

Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider